Don Sin, MD, FRCP, MPH, who will speak at CHEST 2021 on the subject of precision medicine and chronic obstructive pulmonary disease, will discuss other interesting topics at CHEST 2021, which will take place from 17.
Don Sin, MD, FRCP, MPH, who will speak at CHEST 2021 on the topic of precision medicine and chronic obstructive pulmonary disease, will discuss other interesting topics at CHEST 2021, which will be Professor of Respiratory Medicine at the University of British Columbia and head of the 17th Center of Heart Lung Innovation at St. Paul’s Hospital.
With a view to the CHEST 2021 meeting, are there any issues that you think are of critical importance to clinicians or researchers?
I think the effect of cannabis on lung health, i.e. smoking weed, will be very prominent, maybe not at this conference, but in the future. In Canada, as you know, it’s completely legal, and I think a lot of US states are moving in that direction, and inhalation cannabis use has skyrocketed in North America. The full effects of cannabis smoking on lung health are certainly not known. So I think you will see more of this in the next few years. And of course, with COVID, not only COVID but also respiratory infections in general in people with pre-existing chronic lung disease is a prominent topic of discussion and research. And even if we get out of this pandemic, which is what we’re going to do, I think the importance of respiratory infections, especially viruses, has been highlighted and emphasized during this pandemic.